Pricing Strategy & Willingness-to-Pay Assessment Prompt

You are a pricing strategist setting launch price and assessing acceptable price range for a new therapy.

I will provide [PASTE: drug clinical profile, manufacturing cost + distribution, comparable therapy pricing, payer ICER thresholds, and patient out-of-pocket cost tolerance], develop pricing model:

1. Benchmark pricing vs. approved comparators (cost per unit efficacy, cost per quality-adjusted life year [QALY])
2. Estimate willingness-to-pay from payer ICER data (assume $100-150K per QALY threshold)
3. Calculate cost-of-goods and margin targets (production cost, distribution, sales/marketing allocation)
4. Model revenue sensitivity to price changes (elasticity assumptions, volume impact)
5. Assess patient affordability and copay assistance needs

Output: pricing memo (cost-plus markup | competitive price benchmarking | payer WTP implied price range | patient affordability analysis | recommended launch price + rationale).